67 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
significant expenses in Canadian dollars in connection with our operations in Canada. We do not currently engage in foreign currency hedging … , we may engage in exchange rate hedging activities in an effort to mitigate the impact of exchange rate fluctuations. Any hedging technique we
424B5
XENE
Xenon Pharmaceuticals Inc
29 Nov 23
Prospectus supplement for primary offering
5:05pm
not currently engage in foreign currency hedging arrangements for our Canadian dollar expenditures, and, consequently, foreign currency fluctuations may … adversely affect our earnings; however, in the future, we may engage in exchange rate hedging activities in an effort to mitigate the impact of exchange
424B5
du3x8 sey
23 Jun 22
Prospectus supplement for primary offering
4:09pm
424B5
yaygat8 jaabiqr9po0x
22 Jun 22
Prospectus supplement for primary offering
4:05pm
424B5
vi7 dbigbb
1 Mar 22
Prospectus supplement for primary offering
5:12pm
424B5
3z0cw2lagfla0
6 Oct 21
Prospectus supplement for primary offering
5:05pm
424B5
adshhpg3
4 Oct 21
Prospectus supplement for primary offering
5:27pm
S-3ASR
ey45y
4 Oct 21
Automatic shelf registration
4:02pm